Market Cap 40.48M
Revenue (ttm) 0.00
Net Income (ttm) -7.87M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,100
Avg Vol 52,652
Day's Range N/A - N/A
Shares Out 8.87M
Stochastic %K 0%
Beta 0.25
Analysts Strong Sell
Price Target $11.00

Company Profile

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clin...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9349 4906
Address:
500 Collins Street, Level 15, Melbourne, Australia
stckmuncher
stckmuncher Jul. 30 at 3:17 AM
$ATHE HUUUUUUGE
0 · Reply
stckmuncher
stckmuncher Jul. 30 at 3:03 AM
$ATHE ASK AND YOU SHALL GET!!!!!! https://alteritytx.com/announcements/7657880
0 · Reply
Double__Down
Double__Down Jul. 30 at 12:57 AM
$ATHE seems like the route is on their own or partnership. Somewhat expected imo. Might take longer but the buyout will be larger the longer we go..
1 · Reply
stckmuncher
stckmuncher Jul. 29 at 11:15 PM
$ATHE MY DICK AINT GETTING HARD WITH NO NEWS
0 · Reply
stckmuncher
stckmuncher Jul. 29 at 11:14 PM
$ATHE NEWS
0 · Reply
stckmuncher
stckmuncher Jul. 29 at 11:14 PM
$ATHE WHERE IN THE FUCK IS OUR NEWS ON RECENT CONFERENCES?
0 · Reply
Beodong
Beodong Jul. 29 at 10:13 PM
$ATHE volume is so low it’s crazy, wait for a major event to panic or celebrate, now’s not the time.
0 · Reply
ShowM3Th3Mon3y69
ShowM3Th3Mon3y69 Jul. 29 at 8:08 PM
$ATHE “To lose patience is to lose the battle” -Mahatma Ghandi —Money Man Todd
0 · Reply
Double__Down
Double__Down Jul. 28 at 11:13 PM
$ATHE any news from the chat with investors?
0 · Reply
stckmuncher
stckmuncher Jul. 28 at 11:09 PM
$ATHE Conference update please!?
0 · Reply
Latest News on ATHE
Alterity Therapeutics initiated with a Buy at JonesResearch

2026-06-29T20:30:18.000Z - 4 weeks ago

Alterity Therapeutics initiated with a Buy at JonesResearch


Alterity Therapeutics assumed with a Buy at Ladenburg

2026-06-16T11:57:21.000Z - 6 weeks ago

Alterity Therapeutics assumed with a Buy at Ladenburg


Alterity Therapeutics Slides: Corporate presentation

Jun 15, 2026, 6:00 PM EDT - 6 weeks ago

Alterity Therapeutics Slides: Corporate presentation


Alterity Therapeutics management to meet with BTIG

2026-06-03T17:30:12.000Z - 2 months ago

Alterity Therapeutics management to meet with BTIG

ATHE


Alterity Therapeutics Earnings release: Q3 2026

Apr 29, 2026, 6:00 PM EDT - 3 months ago

Alterity Therapeutics Earnings release: Q3 2026


Alterity Therapeutics Transcript: KOL event

Apr 28, 2026, 1:00 PM EDT - 3 months ago

Alterity Therapeutics Transcript: KOL event


Alterity Therapeutics Quarterly report: H1 2026

Feb 24, 2026, 6:00 PM EST - 5 months ago

Alterity Therapeutics Quarterly report: H1 2026


Alterity Therapeutics provides corporate update

2026-01-30T12:38:43.000Z - 6 months ago

Alterity Therapeutics provides corporate update

ATHE


Alterity Therapeutics highlights key 2026 objectives

2026-01-21T12:36:56.000Z - 6 months ago

Alterity Therapeutics highlights key 2026 objectives

ATHE


Alterity Therapeutics Earnings release: Q1 2026

Oct 31, 2025, 7:00 AM EDT - 9 months ago

Alterity Therapeutics Earnings release: Q1 2026


Alterity Therapeutics presents data from ATH434 Phase 2 trial

2025-10-09T11:30:21.000Z - 10 months ago

Alterity Therapeutics presents data from ATH434 Phase 2 trial

ATHE


Alterity Therapeutics Transcript: Biotech Showcase

Sep 2, 2025, 10:30 PM EDT - 11 months ago

Alterity Therapeutics Transcript: Biotech Showcase


Alterity Therapeutics to Present at the Biotech Showcase

Sep 2, 2025, 7:25 AM EDT - 11 months ago

Alterity Therapeutics to Present at the Biotech Showcase

ATHE


Alterity Therapeutics Annual report: H2 2025

Aug 29, 2025, 3:30 AM EDT - 11 months ago

Alterity Therapeutics Annual report: H2 2025


Alterity Therapeutics Slides: Corporate Presentation

Jul 30, 2025, 6:00 PM EDT - 1 year ago

Alterity Therapeutics Slides: Corporate Presentation


Appendix 4C – Q4 FY25 Quarterly Cash Flow Report

Jul 30, 2025, 7:25 AM EDT - 1 year ago

Appendix 4C – Q4 FY25 Quarterly Cash Flow Report

ATHE


Alterity Therapeutics Earnings release: Q4 2025

Jul 29, 2025, 6:00 PM EDT - 1 year ago

Alterity Therapeutics Earnings release: Q4 2025


Appendix 4C – Q3 FY25 Quarterly Cash Flow Report

Apr 30, 2025, 7:35 AM EDT - 1 year ago

Appendix 4C – Q3 FY25 Quarterly Cash Flow Report

ATHE


Alterity Therapeutics Earnings release: Q3 2025

Apr 29, 2025, 6:00 PM EDT - 1 year ago

Alterity Therapeutics Earnings release: Q3 2025


Alterity Therapeutics Quarterly report: H1 2025

Feb 27, 2025, 6:00 PM EST - 1 year ago

Alterity Therapeutics Quarterly report: H1 2025


Alterity Therapeutics Raises A$40.0 million in Placement

Feb 10, 2025, 7:25 AM EST - 1 year ago

Alterity Therapeutics Raises A$40.0 million in Placement


Alterity Therapeutics Transcript: Study Result

Jan 29, 2025, 8:01 PM EST - 1 year ago

Alterity Therapeutics Transcript: Study Result


Alterity Therapeutics Slides: Study Result

Jan 29, 2025, 8:01 PM EST - 1 year ago

Alterity Therapeutics Slides: Study Result


Appendix 4C – Q2 FY25 Quarterly Cash Flow Report

Jan 24, 2025, 7:35 AM EST - 1 year ago

Appendix 4C – Q2 FY25 Quarterly Cash Flow Report


Alterity Therapeutics Slides: Corporate Presentation

Jan 4, 2025, 8:00 PM EST - 1 year ago

Alterity Therapeutics Slides: Corporate Presentation


Appendix 4C – Q1 FY25 Quarterly Cash Flow Report

Oct 31, 2024, 7:35 AM EDT - 1 year ago

Appendix 4C – Q1 FY25 Quarterly Cash Flow Report


Alterity Therapeutics Earnings release: Q1 2025

Oct 30, 2024, 9:00 PM EDT - 1 year ago

Alterity Therapeutics Earnings release: Q1 2025


Alterity Therapeutics Annual report: H2 2024

Sep 26, 2024, 3:30 AM EDT - 2 years ago

Alterity Therapeutics Annual report: H2 2024


Appendix 4C – Q4 FY24 Quarterly Cash Flow Report

Jul 31, 2024, 7:35 AM EDT - 2 years ago

Appendix 4C – Q4 FY24 Quarterly Cash Flow Report


Alterity Therapeutics Earnings release: Q4 2024

Jul 30, 2024, 8:00 PM EDT - 2 years ago

Alterity Therapeutics Earnings release: Q4 2024


Alterity Therapeutics Transcript: Study Update

Jul 24, 2024, 6:30 PM EDT - 2 years ago

Alterity Therapeutics Transcript: Study Update


Alterity Therapeutics to Present at MST Financial Webinar

Jul 24, 2024, 7:35 AM EDT - 2 years ago

Alterity Therapeutics to Present at MST Financial Webinar


stckmuncher
stckmuncher Jul. 30 at 3:17 AM
$ATHE HUUUUUUGE
0 · Reply
stckmuncher
stckmuncher Jul. 30 at 3:03 AM
$ATHE ASK AND YOU SHALL GET!!!!!! https://alteritytx.com/announcements/7657880
0 · Reply
Double__Down
Double__Down Jul. 30 at 12:57 AM
$ATHE seems like the route is on their own or partnership. Somewhat expected imo. Might take longer but the buyout will be larger the longer we go..
1 · Reply
stckmuncher
stckmuncher Jul. 29 at 11:15 PM
$ATHE MY DICK AINT GETTING HARD WITH NO NEWS
0 · Reply
stckmuncher
stckmuncher Jul. 29 at 11:14 PM
$ATHE NEWS
0 · Reply
stckmuncher
stckmuncher Jul. 29 at 11:14 PM
$ATHE WHERE IN THE FUCK IS OUR NEWS ON RECENT CONFERENCES?
0 · Reply
Beodong
Beodong Jul. 29 at 10:13 PM
$ATHE volume is so low it’s crazy, wait for a major event to panic or celebrate, now’s not the time.
0 · Reply
ShowM3Th3Mon3y69
ShowM3Th3Mon3y69 Jul. 29 at 8:08 PM
$ATHE “To lose patience is to lose the battle” -Mahatma Ghandi —Money Man Todd
0 · Reply
Double__Down
Double__Down Jul. 28 at 11:13 PM
$ATHE any news from the chat with investors?
0 · Reply
stckmuncher
stckmuncher Jul. 28 at 11:09 PM
$ATHE Conference update please!?
0 · Reply
motherlandreturns
motherlandreturns Jul. 28 at 11:39 AM
$ATHE Let’s go
0 · Reply
stckmuncher
stckmuncher Jul. 28 at 12:38 AM
$ATHE BIG WEEK! 🚀🚀🚀
0 · Reply
stckmuncher
stckmuncher Jul. 26 at 12:18 PM
$ATHE CONFERENCE IS JUST AROUND THE CORNER🚀🚀🚀
1 · Reply
stckmuncher
stckmuncher Jul. 25 at 2:54 PM
$ATHE DICK GETTING HARDER…HAD A SLIGHT TRICKLE OF DEPRESSION…WE BACK
0 · Reply
stckmuncher
stckmuncher Jul. 24 at 9:24 PM
$ATHE DICK GOING LIMP :(
1 · Reply
tommy_john
tommy_john Jul. 24 at 5:57 PM
$ATHE this needs to bounce back to 5 to confirm a higher high and higher low pattern. No breakdown needed
0 · Reply
GA09
GA09 Jul. 23 at 11:15 PM
$ATHE Amazing Management Team at ATHE. The CEO is extremely passionate about treating MSA wants patients suffering from this devastating disease to get treatment as soon as possible. Of all the biotech companies I have invested in (or invest in), CEO of ATHE is a 5 star CEO. Transparent, honest, passionate, experienced, thorough, meticulous and dedicated towards treating MSA and Parkinson's Disease. A potential partner or acquiring company will be impressed by the CEO.
1 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW Jul. 23 at 10:19 PM
$ATHE corporate staying active on socials, partnership news soon me thinks https://x.com/alterityt/status/2080157206914498832?s=46
0 · Reply
ShowM3Th3Mon3y69
ShowM3Th3Mon3y69 Jul. 23 at 3:20 PM
$ATHE selling under $5 is going to be the same in 20 years as people selling Amazon in 2006. We are sitting on a first in the world technology when it comes to neurological disease treatment. Key word treatment. For the first time a medication will ATTACK the diseased cells in your brain to TREAT the disease; not just mask the symptoms for comfort. This is truly revolutionary. Although this technology is initially being utilized to treat MSA, I predict this to evolve over the next decade or two as the baseline for many other disease treatments. Similar to how Amazon started by selling used books, they have evolved into a world changing organization. Like I said, selling below $5 is going to feel like selling Amazon in 2006. That being said, I am appreciative for the dummies selling below $5 because it allows me the opportunity to continue stacking. Each share acquired today will ensure my children’s children’s children are set for life. We are truly sitting on a world changing biotech.
0 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW Jul. 22 at 8:49 PM
$ATHE hold fast lads, dont let the shorts steal your shares!
0 · Reply
GA09
GA09 Jul. 22 at 2:43 PM
$ATHE Is CEO talking to investors at the BTIG Conference because, 1) ongoing discussions with pharma have not yet finalized, or 2) pharma companies have not shown interest in 434, or 3) offering price for partnership or acquisition is not acceptable by CEO and Board Members. CEO has stated that pharma companies have shown interest in 434 and they have been having discussions. Any thoughts?
1 · Reply
GA09
GA09 Jul. 21 at 12:29 PM
$ATHE ATHE to present at BTIG Investor Conference where CEO will be speaking 1 - 1 with investors.
0 · Reply